PEGINESATIDE ACETATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for peginesatide acetate and what is the scope of patent protection?
Peginesatide acetate
is the generic ingredient in two branded drugs marketed by Takeda Pharms Usa and is included in one NDA. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.Peginesatide acetate has one hundred and fourteen patent family members in thirty-four countries.
Summary for PEGINESATIDE ACETATE
International Patents: | 114 |
US Patents: | 6 |
Tradenames: | 2 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | PEGINESATIDE ACETATE at DailyMed |
US Patents and Regulatory Information for PEGINESATIDE ACETATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-001 | Mar 27, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-006 | Mar 27, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-004 | Mar 27, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-003 | Mar 27, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Takeda Pharms Usa | OMONTYS | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-008 | Mar 27, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PEGINESATIDE ACETATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-005 | Mar 27, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
Takeda Pharms Usa | OMONTYS | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-008 | Mar 27, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
Takeda Pharms Usa | OMONTYS | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-007 | Mar 27, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
Takeda Pharms Usa | OMONTYS | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-008 | Mar 27, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
Takeda Pharms Usa | OMONTYS | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-008 | Mar 27, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PEGINESATIDE ACETATE
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 1629007 | ⤷ Try a Trial | |
World Intellectual Property Organization (WIPO) | 2004101606 | ⤷ Try a Trial | |
Montenegro | 00356 | Novi peptidi koji se vezuju za receptor eritropoietina (Novel peptides that bind to the erythropoietin receptor) | ⤷ Try a Trial |
Japan | 2009108061 | NEW PEPTIDE THAT BINDS TO ERYTHROPOIETIN RECEPTOR | ⤷ Try a Trial |
New Zealand | 563433 | Erythropoietin receptor peptide formulations and uses | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |